Grown up in Athens, Greece Ludwig Kappos obtained his M.D. and a Diploma in Clinical Psychology from the University of Würzburg, Germany. From 2008 until end of 2020 he was Chair of Neurology at the University of Basel, Switzerland. Since 2019 he is Director of the Research Center of Clinical Neuroimmunology and Neuroscience Basel (RC2NB).
Ludwig Kappos has served as lead investigator of the pivotal phase 2 and 3 studies for most currently approved MS-treatments. His research interests include methodology of therapeutic studies, standardisation of clinical assessments, development of digital and laboratory biomarkers, cellular and molecular studies in neuroimmunological diseases and use of magnetic resonance imaging in elucidating the pathogenesis of inflammatory CNS disease and as tool to monitor therapeutic effects and defining prognosis.
Ludwig Kappos has published more than 750 original papers, reviews and book chapters and has been awarded with several prizes and honorary doctorates for his scientific contributions.